Delivery Order SPE2DE24D0013-SPE2D625F3VGB

Cepheid, a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $13,096.80 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and is scheduled for completion by October 2, 2025. Based on the contract designation and Cepheid's core product offerings, this delivery order appears to procure molecular diagnostic test kits or reagents for detection of COVID-19, influenza, and respiratory syncytial virus (RSV), consistent with the company's GeneXpert diagnostic system capabilities.

This award likely represents a delivery order issued under one of Cepheid's existing indefinite delivery vehicle contracts with the Department of Veterans Affairs or Defense Health Agency. Cepheid maintains substantial IDV contracts with the VA, including a single-award vehicle valued at $32.8 million through September 2030 that supplies molecular diagnostic testing system reagents and assays. The company's federal contracting profile demonstrates consistent delivery of diagnostic solutions to military and veteran healthcare systems, positioning this relatively modest delivery order within a broader framework of ongoing federal procurement of advanced diagnostic capabilities for infectious disease detection across the Defense Department's healthcare infrastructure.